Journal of Heart and Cardiovascular Research

Opinion Article: J Heart Cardiovasc Res (1-2)

Empagliflozin's protection against lipid peroxidation and cardiomyocyte dysfunction

Author(s): Minzhi Yunshan

DOI: 10.36648/ipjhcr.6.5.27

Full-Text | PDF

Opinion Article: J Heart Cardiovasc Res (1-2)

Chemotherapeutic Medication Known As Doxorubicin Can Be Used To Treat a Variety of Tumors

Author(s): Kaoru Nakano

DOI: 10.36648/ipjhcr.6.5.23

Full-Text | PDF

Perspective Article: J Heart Cardiovasc Res (1-2)

Anthracyclines Keep Playing an Irreplaceable Position in Oncology Remedy

Author(s): Chiaparini Leiria

DOI: 10.36648/ipjhcr.6.5.24

Full-Text | PDF

Commentary: J Heart Cardiovasc Res (1-2)

T-2 Toxin Is One of the Maximum Poisonous and Not Unusualplace Trichothecene Mycotoxins

Author(s): Tony Jianzhong

DOI: 10.36648/ipjhcr.6.5.25

Full-Text | PDF

Perspective Article: J Heart Cardiovasc Res (1-2)

Pirarubicin Is an Anthracycline Antibiotic Used To Deal With Diverse Malignancies in Humans

Author(s): Malgorzata Wnorowski

DOI: 10.36648/ipjhcr.6.5.26

Full-Text | PDF